Looking for some juicy dividend yields for your income portfolio? If you are, then take a look at the two ASX dividend shares listed below.
They have been named as buys and tipped to provide investors with some mouth-watering yields in the near term. Here's what analysts are recommending:
Image source: Getty Images
GQG Partners Inc (ASX: GQG)
The first ASX dividend share that could be a buy for income investors is GQG Partners.
It is a global investment boutique focused on managing active equity portfolios. At the last count, it managed US$159.5 billion for investors that include many large pension funds, sovereign funds, wealth management firms, and other financial institutions around the world.
Goldman Sachs thinks that its shares are being undervalued by the market right now. They recently said:
We retain our Buy rating on GQG: We lower our PT to $2.80 from A$3.00 to reflect the relatively muted impact on flows to date despite an outsized share price reaction resulting in a year P/E of <9x. We've moderated our flows reflecting some slowdown, albeit manageable in our view.
As for income, the broker is forecasting some very large dividend yields in the near term. It is expecting dividends per share of 15 US cents (24.1 Australian cents) in FY 2025 and then 17 US cents (27.3 Australian cents) in FY 2026. Based on the current GQG Partners share price of $2.10, this would mean dividend yields of 11.5% and 13%, respectively.
Goldman has a buy rating and $2.80 price target on its shares.
Healthco Healthcare and Wellness REIT (ASX: HCW)
Another ASX dividend share that could offer very big yields is the Healthco Healthcare and Wellness REIT.
It is a real estate investment trust focused on owning healthcare and wellness property assets.
The company notes that its objective is to provide exposure to a diversified portfolio underpinned by healthcare sector megatrends, targeting stable and growing distributions, long-term capital growth and positive environmental and social impact.
Bell Potter believes that its shares are undervalued at current levels given its positive outlook. The broker recently said:
With +5% earnings growth expected for FY25, we see value in HCW at current levels with the buyback putting a floor under the share price and HCW continuing to deliver from a property perspective. At a +7% DPS yield and meaningful discount to NTA, HCW screens attractively on a sector-relative basis.
It is forecasting dividends per share of 8.4 cents in FY 2025 and then 8.8 cents FY 2026. Based on the current Healthco Healthcare and Wellness REIT unit price of $1.03, this will mean dividend yields of 8.15% and 8.5%, respectively.
Bell Potter currently has a buy rating and $1.50 price target on its shares.
